[ Pharmaceutical Sciences Asia - ONLINE ]
E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: https://doi.org/10.29090/psa.2018.01.037Pharm Sci Asia 2018; 45(1), 37-44
 

Investigation on colistin use at the University Medical Center Hochiminh City

T.C. Bang, D.N.D. Trang

1 Department of Clinical Pharmacy, Faculty of Pharmacy, University of Medicine and Pharmacy, Hochiminh City, Vietnam
2 Department of Pharmacy, University Medical Center Hochiminh City, University of Medicine and Pharmacy, Hochiminh City, Vietnam


The upsurge of multi-resistant gram-negative pathogen highlights the role of colistin as the last-line antimicrobial agent in the treatment of severe infections all over the world. Recently, the increase of colistin use at University Medical Center Hochiminh City (UMC) has raised the concern about the potential resistance of microbes against this antibiotic. The aim of this study is to evaluate rational colistin indication and to identify factors which may be attributed to nephrotoxicity. One hundred and two in-patients indicated with colistin for 72 hours or more from January to December 2016 were enrolled in a descriptive cross-sectional study at University Medical Center HCMC. Medical records of patients were reviewed for data analysis. Risk, Injury, Failure, Loss of kidney function, and End-stage kidney diseases (RIFLE) criteria was used to evaluate nephrotoxicity during treatment. The median age of the study population was 77.5, 64.7% were male and 63 patients (61.8%) were treated in the ICU. The most common comorbidities were cardiovascular diseases (70.6%). Acinetobacter baumannii accounted for 35.76% of 4 common pathogens but no resistance to colistin was found during the study period. The average daily colistin dose per kilogram was 97,26 ± 35,21 IU and the average duration of intravenous colistin was 13.05 ± 6.67 days. Rational use of colistin was observed in only 32.8% of the study population. Twelve patients (11.76%) experienced nephrotoxicity after the course of treatment using RIFLE criteria. Logistic regression analysis showed that age (OR = 1.059; 95% CI 1.020-1.087, p = 0.004), respiratory diseases (OR = 0.139; 95% CI 0.024-0.804, p = 0.028), concomitant use with furosemide (OR = 6,215; 95% CI 1.002-38.565, p = 0.049) or amphotericin B (OR = 29.995; 95% CI 2.638-341.007, p = 0.006) were significantly associated with nephrotoxicity



Keyword:

Colistin; Resistance; Rational use; Nephrotoxicity




Download full paper (PDF File size: 1,134.07 KB.)





Vol.45
No.4
October - December 2018

See other volume

 


Vol.45
No.3
July - September 2018

See other volume

 


Vol.45
No.2
April - June 2018

See other volume

 


Vol.45
No.1
January - March 2018

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



Pharmaceutical Sciences Asia by Faculty of Pharmacy, Mahidol University, Thailand is licensed under CC BY-NC-ND 4.0

    Copyright © 2017-2024
    Faculty of Pharmacy, Mahidol University, THAILAND
 

We use Cookies

This site uses cookies to personalise your experience and analyse site traffic. By Clicking ACCEPT or continuing to browse the site you are agreeing to our use of cookies.